Skip to main content

Fitch downgrades Tufts Medicine's IDR to 'BBB', outlook remains negative

By Fitch Ratings  
   March 01, 2023

The downgrade to 'BBB' and the Negative Outlook reflect a sizable operating loss at TM in FY22 (Sept. 30 YE), a material decline in unrestricted liquidity, and the execution risk related to TM's ability to stabilize operations and rebuild its unrestricted liquidity.

Full story

Tagged Under:


Get the latest on healthcare leadership in your inbox.